Poster presentation highlights SMART adenine base editors (ABEs) small enough to be packaged into a single adeno-associated virus (AAV) ...
4h
NUZ is advancing its lead drug monepantel, now known as NUZ-001, for the treatment of neurodegenerative diseases, starting ...
HUNTINGTON Jacob Harper, a 23-year-old fighting a rare form of ALS (amyotrophic lateral sclerosis), has become a beacon of hope for many. Diagnosed in 2022 and the youngest person in the state of West ...
A toxic version of a certain protein may affect brain, spinal cord and skeletal muscle tissues differently, leading to the ...
The Drug Enforcement Agency is considering changing marijuana from a Schedule I drug to Schedule III. What would that mean?
NeuroSense plans to apply to Canada’s regulators for early marketing approval of the oral therapy, supported by a Phase 2b ...
True to its history of reinvention and repurposing, Pharmaust will be renamed Neurizon Therapeutics after shareholders ...
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis (ALS), are characterized by the progressive loss of structure and function of neurons, ...
INDIANAPOLIS – Living Room Theaters slowly came to life Saturday morning on the third day of the 33rd Heartland International ...
The inaugural 2024 CEO Soak Tallahassee is a fundraising initiative aimed at making a significant impact on ALS research and care for ALS patients.
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two devastating neurodegenerative diseases. Scientists have long suspected a protein called FUS might play a role, but the ...
Folks came together at Columbia Point Park in Richland Saturday to help raise money and awareness aboutAmyotrophic lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback